Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02452840 · ClinicalTrials.gov registry record
Photodynamic Therapy for PDA in NV AMD
A clinical trial, sponsored by Duke University.
- Completed
- Registry status
- 100
- Enrollment target
NCT02452840 is a clinical trial that has completed, run by Duke University. The registered enrollment target is 100 participants.
The verdict
NCT02452840 has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- 100 participants
- Enrollment target
Study Summary
The purpose of this prospective observational study is to assess the potential clinical effects of adjunctive verteporfin photodynamic therapy (PDT) for persistent disease activity among patients with neovascular age-related macular degeneration (NV AMD). No specific interventions will occur as part of the study; participating subjects undergoing PDT as part of standard-of-care will be asked to consent to prospective collection of data from their medical records for up to five years from the date of consent, including results from ophthalmologic exams, imaging, and treatments. The primary study outcome will be the percentage of subjects with resolution of persistent disease activity at six months post-PDT treatment. Aside from a small risk of loss of confidentiality, risks associated with this study are no greater than those related to standard of care.
Interventions
- OTHER No Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2015-05-11 |
| Est. Completion | 2019-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02452840
The ClinicalTrials.gov registry entry for NCT02452840 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which No Intervention is the first listed.
NCT02452840 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02452840 about?
NCT02452840 is a clinical study titled "Photodynamic Therapy for PDA in NV AMD". The purpose of this prospective observational study is to assess the potential clinical effects of adjunctive verteporfin photodynamic therapy (PDT) for persistent disease activity among patients with neovascular age-related macular degeneration (NV AMD). No specific interventions will occur as part...
What is the current status of trial NCT02452840?
This trial is currently completed. The enrollment target is 100 participants. The study started on 2015-05-11. Estimated completion is 2019-08.
What interventions are being tested in trial NCT02452840?
The interventions under investigation include: No Intervention (OTHER).
Who is sponsoring clinical trial NCT02452840?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.